150 related articles for article (PubMed ID: 1165881)
1. Progesterone and estradiol patterns in women using an intrauterine contraceptive device.
Brenner PF; Mishell DR
Obstet Gynecol; 1975 Oct; 46(4):456-9. PubMed ID: 1165881
[TBL] [Abstract][Full Text] [Related]
2. Hormonal profile in IUD users.
Souka AR; Rahman H; Osman M; Mohei Y; Rizk M
Contracept Deliv Syst; 1981 Oct; 2(4):303-10. PubMed ID: 12336991
[TBL] [Abstract][Full Text] [Related]
3. The effect of the copper-T 200 IUD on the luteal phase plasma progesterone concentration in the normal menstrual cycle.
Haukkamaa M; Luukkainen T; Timonen H
Ann Clin Res; 1974 Feb; 6(1):40-4. PubMed ID: 4820609
[TBL] [Abstract][Full Text] [Related]
4. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
[TBL] [Abstract][Full Text] [Related]
5. Hormonal evaluation of the intrauterine progesterone contraceptive system.
Bryand-Greenwood GD; Greenwood FC; Hale RW; Morishige WK
J Clin Endocrinol Metab; 1977 Apr; 44(4):721-7. PubMed ID: 849982
[TBL] [Abstract][Full Text] [Related]
6. Levels of serum steroid hormones in intrauterine contraceptive device users.
Fahmy K; el-Gazar A; Eisa I; Ghonaim M; Saad S; Afifi A
Gynecol Endocrinol; 1991 Mar; 5(1):1-5. PubMed ID: 1897380
[TBL] [Abstract][Full Text] [Related]
7. The menstrual cycle in women using an intrauterine device.
Faundes A; Segal SJ; Adejuwon CA; Brache V; Leon P; Alvarez-Sanchez F
Fertil Steril; 1980 Nov; 34(5):427-30. PubMed ID: 7439408
[TBL] [Abstract][Full Text] [Related]
8. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
[TBL] [Abstract][Full Text] [Related]
9. LH, FSH, estradiol and progesterone levels after discontinuation of hormonal contraception.
Balogh A; Ditrói F; Lampé LG
Acta Univ Palacki Olomuc Fac Med; 1981; 101():95-101. PubMed ID: 6242699
[TBL] [Abstract][Full Text] [Related]
10. Hormonal characteristics in the early luteal phase of conceptive and nonconceptive menstrual cycles.
Chen J; Qiu Q; Lohstroh PN; Overstreet JW; Lasley BL
J Soc Gynecol Investig; 2003 Jan; 10(1):27-31. PubMed ID: 12517590
[TBL] [Abstract][Full Text] [Related]
11. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Croxatto HB; Salvatierra AM; Romero C; Spitz IM
J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
[TBL] [Abstract][Full Text] [Related]
12. Luteolytic activity of LHRH and [D-Ser(TBU)6, des-Gly-NH2(10)]LHRH ethylamide: a new and physiological approach to contraception in women.
Lemay A; Labrie F; Raynaud JP
Int J Fertil; 1980; 25(3):203-12. PubMed ID: 6108931
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ovulation by a new low-dose monophasic contraceptive containing gestodene.
Thomas KH; Vankrieken L
Int J Fertil; 1989 Sep; 34 Suppl():10-21. PubMed ID: 2576249
[TBL] [Abstract][Full Text] [Related]
14. Luteal deficiency among women with normal menstrual cycles, requesting reversal of tubal sterilization.
Radwanska E; Berger GS; Hammond J
Obstet Gynecol; 1979 Aug; 54(2):189-92. PubMed ID: 460752
[TBL] [Abstract][Full Text] [Related]
15. Effect of repeated hyperbaric exposures on the menstrual cycle: preliminary study.
Willson JR; Blessed WB; Blackburn PJ
Undersea Biomed Res; 1984 Mar; 11(1):91-7. PubMed ID: 6429915
[TBL] [Abstract][Full Text] [Related]
16. Hormonal and menstrual changes after laparoscopic sterilization by Falope-rings or Filshie-clips.
Thranov I; Hertz JB; Kjer JJ; Andresen A; Micic S; Nielsen J; Hancke S
Fertil Steril; 1992 Apr; 57(4):751-5. PubMed ID: 1532561
[TBL] [Abstract][Full Text] [Related]
17. Serum ovarian steroids, prolactin and prostaglandin metabolites in women using the inert intrauterine device.
Shalev E; Harpaz-Kerpel S; Engelhard Y; Weiner E; Eran A; Zuckerman H
Int J Gynaecol Obstet; 1987 Apr; 25(2):139-44. PubMed ID: 2884139
[TBL] [Abstract][Full Text] [Related]
18. The effect of intrauterine progesterone on the DNA-content in isolated human endometrial cells.
Johannisson E; Langren BM; Hagenfeldt K
Acta Cytol; 1977; 21(3):441-6. PubMed ID: 268127
[TBL] [Abstract][Full Text] [Related]
19. Relationship between symptom severity and hormone changes in women with premenstrual syndrome.
Hammarbäck S; Damber JE; Bäckström T
J Clin Endocrinol Metab; 1989 Jan; 68(1):125-30. PubMed ID: 2491857
[TBL] [Abstract][Full Text] [Related]
20. [A histological and hormonal study of 399 women near the menopause or with confirmed menopause (author's transl)].
Trevoux R; De Brux J; Grenier J; Roger M; Bailleul S; Scholler R
J Gynecol Obstet Biol Reprod (Paris); 1979; 8(1):13-22. PubMed ID: 469196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]